Small Cap BSE: 541540 NSE: SOLARA
4.05 (0.98%)
  • Advice
  • Hold
As on 02 October, 2022 | 17:57

Solara Active Pharma Sciences Share Price

Solara Active Pharma Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume


Start SIP

Solara Active Pharma Sciences Share Returns

  • Over 1 Month -7.74%
  • Over 3 Month 18.27%
  • Over 6 Month -39.74%
  • Over 1 Year -73.95%

Solara Active Pharma Sciences Key Statistics

P/E Ratio -12
PEG Ratio 0.1
Market Cap Cr 1,501
Price to Book Ratio 1
EPS -15.1
Dividend 0
Relative Strength Index 44.68
Money Flow Index 60.79
MACD Signal 5.11
Average True Range 20.94

Solara Active Pharma Sciences Investment Rating

  • Master Rating:
  • Solara Active Pharma Scis has an operating revenue of Rs. 1,192.84 Cr. on a trailing 12-month basis. An annual revenue de-growth of -22% needs improvement, Pre-tax margin of -7% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a FAIR score but needs to improve its earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 127 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Solara Active Pharma Sciences Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 330361100402406444
Operating Expenses Qtr Cr 320348197329314345
Operating Profit Qtr Cr 1013-977292100
Depreciation Qtr Cr 282828282827
Interest Qtr Cr 232118171925
Tax Qtr Cr -15-330000
Net Profit Qtr Cr -190-140305157

Solara Active Pharma Sciences Technicals


Current Price
3.7 (0.9%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 432.82
  • 50 Day
  • 426.79
  • 100 Day
  • 467.31
  • 200 Day
  • 615.08
  • 20 Day
  • 439.91
  • 50 Day
  • 416.61
  • 100 Day
  • 401.56
  • 200 Day
  • 613.35

Solara Active Pharma Sciences Resistance and Support

First Resistance 424.84
Second Resistance 436.72
Third Resistance 446.14
RSI 44.68
MFI 60.79
MACD Single Line 5.12
MACD -0.48
First Resistance 403.54
Second Resistance 394.12
Third Resistance 382.24

Solara Active Pharma Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 50,804 2,146,469 42.25
Week 89,103 3,824,318 42.92
1 Month 128,675 5,944,775 46.2
6 Month 196,062 7,656,207 39.05

Solara Active Pharma Sciences Result Highlights

Solara Active Pharma Sciences Synopsis


Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1268.34 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2022. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.
Market Cap 1,500
Sales 1,193
Shares in Float 2.16
No of funds 62
Book Value 0.98
U/D Vol ratio 1.4
LTDebt / Equity 19
Alpha -0.45
Beta 0.87

Solara Active Pharma Sciences

Owner NameJun-22Mar-22Dec-21
Promoters 40.4%39.71%39.51%
Mutual Funds 2.74%3.29%4.85%
Foreign Portfolio Investors 17.93%19.42%18.15%
Financial Institutions/ Banks 0.1%0.1%0.53%
Individual Investors 16.61%17.42%16.36%
Others 22.22%20.06%20.6%

Solara Active Pharma Sciences Management

Name Designation
Mr. Aditya Puri Chairman
Mr. Jitesh Devendra Managing Director
Mr. S Hariharan Executive Director & CFO
Mr. Ankur Nand Thadani Non Executive Director
Mr. Arun Kumar Non Executive Director
Mr. Kartheek Raju Non Executive Director
Mr. Nirmal Bhogilal Independent Director
Mr. R Ramakrishnan Independent Director
Dr. Kausalya Santhanam Independent Director
Ms. Vineeta Rai Independent Director

Solara Active Pharma Sciences Forecast

Price Estimates


Other Analyst Rating

Solara Active Pharma Sciences Corporate Action

Date Purpose Remarks
2022-08-04 Quarterly Results
2022-04-29 Audited Results & Dividend
2022-02-09 Quarterly Results
2021-11-11 Quarterly Results
2021-08-04 Quarterly Results

Solara Active Pharma Sciences MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 16103
Aditya Birla Sun Life Multi-Cap Fund Regular Growth 3755
Aditya Birla Sun Life Mid Cap Fund Growth 3601
SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl 1675
Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth 707

Solara Active Pharma Sciences FAQs

What is Share Price of Solara Active Pharma Sciences ?

Solara Active Pharma Sciences share price is ₹417 As on 02 October, 2022 | 17:43

What is the Market Cap of Solara Active Pharma Sciences ?

The Market Cap of Solara Active Pharma Sciences is ₹1501 Cr As on 02 October, 2022 | 17:43

What is the P/E ratio of Solara Active Pharma Sciences ?

The P/E ratio of Solara Active Pharma Sciences is -12 As on 02 October, 2022 | 17:43

What is the PB ratio of Solara Active Pharma Sciences ?

The PB ratio of Solara Active Pharma Sciences is 1 As on 02 October, 2022 | 17:43